™Your Policy Risk Impact Agent
33 chapters · 625 sections in this title.
RCW 69.77.040 Patient eligibility for access and treatment with investigational product.
1.5K chars
A patient is eligible to request access to and be treated with an investigational product if: (1) The patient is eighteen years of age or older; (2) The patient is a resident of this state; (3) The patient's treating physician attests to the fact that the patient has a serious or…
RCW 69.77.050 Informed consent.
2.2K chars
(1) Prior to treatment of the eligible patient with an investigational product, the treating physician shall obtain written informed consent, consistent with the requirements of RCW 7.70.060(1), and signed by the eligible patient or, if the patient lacks the capacity to consent, …
RCW 69.77.060 Issuer may provide coverage for cost or administration of investigational product—Denial of coverage.
1.1K chars
(1) An issuer may, but is not required to, provide coverage for the cost or the administration of an investigational product provided to an eligible patient pursuant to this chapter. (2)(a) An issuer may deny coverage to an eligible patient who is treated with an investigational …
RCW 69.77.070 Hospitals and health care facilities.
0.7K chars
A hospital or health care facility: (1) May, but is not required to, allow a health care practitioner who is privileged to practice or who is employed at the hospital or health care facility to treat, administer, or provide an investigational product to an eligible patient under …
